Questions and Answers (Verified Answers
by Expert)
1. What is the main benefit of neoadjuvant chemotherapy for a
patient with breast cancer?
A. It always improves overall survival compared with adjuvant
chemotherapy
B. It eliminates the need for radiation therapy
C. It may shrink the tumor enough to allow breast-conserving surgery
D. It prevents all future recurrence of breast cancer
Answer C. It may shrink the tumor enough to allow breast-conserving
surgery
Rationale: Neoadjuvant chemotherapy is given before surgery. It does
not necessarily improve survival compared with adjuvant therapy, but
it may shrink the tumor enough to change surgical options, such as
allowing a lumpectomy plus radiation instead of a mastectomy.
2. Due to Mrs. Turner’s age and comorbidities, her oncologist
,performs a comprehensive geriatric assessment. This assessment
covers all of the following areas except:
A. Functional status
B. Cognitive function
C. Tumor receptor status
D. Nutritional status
Answer C. Tumor receptor status
Rationale: A comprehensive geriatric assessment evaluates older
adults for issues such as functional status, cognition, nutrition,
comorbidities, psychosocial distress, socioeconomic concerns,
polypharmacy, and medication review. Tumor receptor status is part
of cancer staging and treatment planning, but it is not a component
of the geriatric assessment itself.
3. According to NCCN Older Adult Oncology Guidelines, more than
60% of cancers in the United States occur in people age ______ and
older.
A. 50
B. 55
C. 60
D. 65
,Answer D. 65
Rationale: Cancer incidence increases with age. More than 60% of
cancers in the United States occur in adults 65 years of age and
older, making geriatric assessment especially important in oncology
care.
4. Mrs. Turner is receiving docetaxel and carboplatin as part of her
chemotherapy regimen. What is the best explanation for why she was
given a port for chemotherapy administration?
A. A port is required for all chemotherapy agents
B. Her older age requires central venous access
C. Docetaxel and carboplatin are irritants, and a port may reduce
venous irritation and extravasation risk
D. A port prevents all chemotherapy side effects
Answer C. Docetaxel and carboplatin are irritants, and a port may
reduce venous irritation and extravasation risk
Rationale: Docetaxel and carboplatin are commonly categorized as
irritants. Docetaxel can cause significant local reaction if